These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 25159255

  • 1. Emergency surgery and trauma in patients treated with the new oral anticoagulants: dabigatran, rivaroxaban, and apixaban.
    Moorman ML, Nash JE, Stabi KL.
    J Trauma Acute Care Surg; 2014 Sep; 77(3):486-94; quiz 486-94. PubMed ID: 25159255
    [No Abstract] [Full Text] [Related]

  • 2. [Bleeding and surgery in the treatment with new oral anticoagulants. The management can be complicated by the lack of specific antidotes].
    Dalén M, Hjemdahl P, Holmström M, Ivert T.
    Lakartidningen; 2014 Sep; 111(24):1064-8. PubMed ID: 25129916
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacologic interventions for reversing the effects of oral anticoagulants.
    Kalus JS.
    Am J Health Syst Pharm; 2013 May 15; 70(10 Suppl 1):S12-21. PubMed ID: 23640528
    [Abstract] [Full Text] [Related]

  • 4. Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.
    Prescrire Int; 2013 Jun 15; 22(139):155-9. PubMed ID: 23866358
    [Abstract] [Full Text] [Related]

  • 5. Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban.
    Fawole A, Daw HA, Crowther MA.
    Cleve Clin J Med; 2013 Jul 15; 80(7):443-51. PubMed ID: 23821689
    [Abstract] [Full Text] [Related]

  • 6. [New oral anticoagulant agents: the quandary of anticoagulation in the elderly].
    Páramo JA.
    Med Clin (Barc); 2013 Oct 19; 141(8):346-8. PubMed ID: 23831406
    [No Abstract] [Full Text] [Related]

  • 7. The novel anticoagulants: the surgeons' prospective.
    Shamoun FE, Martin EN, Money SR.
    Surgery; 2013 Mar 19; 153(3):303-7. PubMed ID: 23218887
    [Abstract] [Full Text] [Related]

  • 8. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
    Harenberg J, Marx S, Diener HC, Lip GY, Marder VJ, Wehling M, Weiss C.
    Int Angiol; 2012 Aug 19; 31(4):330-9. PubMed ID: 22801398
    [Abstract] [Full Text] [Related]

  • 9. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S, Ansell J.
    Thromb Haemost; 2012 Sep 19; 108(3):476-84. PubMed ID: 22740145
    [Abstract] [Full Text] [Related]

  • 10. Managing new oral anticoagulants in the intensive care unit.
    Gass JA, Weeks PA.
    Crit Care Nurs Q; 2013 Sep 19; 36(4):390-9. PubMed ID: 24002428
    [Abstract] [Full Text] [Related]

  • 11. Reversal of new oral anticoagulants.
    Battinelli EM.
    Circulation; 2011 Oct 04; 124(14):1508-10. PubMed ID: 21969317
    [No Abstract] [Full Text] [Related]

  • 12. New approaches to reversing oral anticoagulant therapy. Introduction.
    Nutescu EA.
    Am J Health Syst Pharm; 2013 May 15; 70(10 Suppl 1):S1-2. PubMed ID: 23640527
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New oral anticoagulants for non-valvular atrial fibrillation--safety issues.
    Barry M.
    Ir Med J; 2013 Mar 15; 106(3):69. PubMed ID: 23951972
    [No Abstract] [Full Text] [Related]

  • 15. Renal risk stratification with the new oral anticoagulants (July 2013).
    Pazmiño P.
    Cleve Clin J Med; 2013 Nov 15; 80(11):733-4. PubMed ID: 24186892
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The new oral anticoagulants in clinical practice.
    Gonsalves WI, Pruthi RK, Patnaik MM.
    Mayo Clin Proc; 2013 May 15; 88(5):495-511. PubMed ID: 23639500
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.